127 related articles for article (PubMed ID: 22088964)
1. Diversity of human leukemia xenograft mouse models: implications for disease biology.
Meyer LH; Debatin KM
Cancer Res; 2011 Dec; 71(23):7141-4. PubMed ID: 22088964
[TBL] [Abstract][Full Text] [Related]
2. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of leukemic stem cells through the xenotransplantation model.
Bonnet D
Curr Protoc Stem Cell Biol; 2008 Dec; Chapter 3():Unit 3.2. PubMed ID: 19085977
[TBL] [Abstract][Full Text] [Related]
4. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
Dialynas DP; Shao L; Billman GF; Yu J
Stem Cells; 2001; 19(5):443-52. PubMed ID: 11553853
[TBL] [Abstract][Full Text] [Related]
5. Murine models of human acute myeloid leukemia.
Fortier JM; Graubert TA
Cancer Treat Res; 2010; 145():183-96. PubMed ID: 20306252
[TBL] [Abstract][Full Text] [Related]
6. Establishment of human tumor xenografts in immunodeficient mice.
Morton CL; Houghton PJ
Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
[TBL] [Abstract][Full Text] [Related]
7. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Dürig J; Ebeling P; Grabellus F; Sorg UR; Möllmann M; Schütt P; Göthert J; Sellmann L; Seeber S; Flasshove M; Dührsen U; Moritz T
Cancer Res; 2007 Sep; 67(18):8653-61. PubMed ID: 17875705
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
9. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
Uesato N; Fukui K; Maruhashi J; Tojo A; Tajima N
Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic considerations of xenograft mouse models of acute leukemia.
Guihard S; Peyrouze P; Cheok MH
Pharmacogenomics; 2012 Nov; 13(15):1759-72. PubMed ID: 23171339
[TBL] [Abstract][Full Text] [Related]
11. Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis.
Cravens PD; Melkus MW; Padgett-Thomas A; Islas-Ohlmayer M; Del P Martin M; Garcia JV
Stem Cells; 2005 Feb; 23(2):264-78. PubMed ID: 15671149
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a bioluminescent imaging-based in vivo leukemia model by intra-bone marrow injection.
Lee MW; Kim HJ; Yoo KH; Kim DS; Yang JM; Kim HR; Noh YH; Baek H; Kwon H; Son MH; Lee SH; Cheuh HW; Jung HL; Sung KW; Koo HH
Int J Oncol; 2012 Dec; 41(6):2047-56. PubMed ID: 23007607
[TBL] [Abstract][Full Text] [Related]
13. Creation and characterization of a xenograft model for human cervical cancer.
Hoffmann C; Bachran C; Stanke J; Elezkurtaj S; Kaufmann AM; Fuchs H; Loddenkemper C; Schneider A; Cichon G
Gynecol Oncol; 2010 Jul; 118(1):76-80. PubMed ID: 20441999
[TBL] [Abstract][Full Text] [Related]
14. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
Bonnet D; Bhatia M; Wang JC; Kapp U; Dick JE
Bone Marrow Transplant; 1999 Feb; 23(3):203-9. PubMed ID: 10084250
[TBL] [Abstract][Full Text] [Related]
15. Preclinical testing of antileukemic drugs using an in vivo model of systemic disease.
Lock RB; Liem NL; Papa RA
Methods Mol Med; 2005; 111():323-34. PubMed ID: 15911988
[TBL] [Abstract][Full Text] [Related]
16. SCID mouse models of human stem cell engraftment.
Greiner DL; Hesselton RA; Shultz LD
Stem Cells; 1998; 16(3):166-77. PubMed ID: 9617892
[TBL] [Abstract][Full Text] [Related]
17. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
Fusetti L; Pruneri G; Gobbi A; Rabascio C; Carboni N; Peccatori F; Martinelli G; Bertolini F
Cancer Res; 2000 May; 60(9):2527-34. PubMed ID: 10811135
[TBL] [Abstract][Full Text] [Related]
18. Cellular-based therapies to prevent or reduce thrombocytopenia.
Pineault N; Boyer L
Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
[TBL] [Abstract][Full Text] [Related]
19. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
[TBL] [Abstract][Full Text] [Related]
20. [Humanized model for acute myeloid leukemia].
Ishikawa F
Nihon Rinsho; 2009 Oct; 67(10):1984-90. PubMed ID: 19860202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
